"frogdreaming,"
Yet, we have reports from others, including journalists/bloggers, of AncestryByDNA test results having been delivered to customers, in recent months. Your claim, that "apparently DNAG is no longer providing test results to it's vendors," does not appear to be supported by the available evidence.
Is there a backlog, and associated delays? Reportedly, yes. Could there be cases where longer-than-usual delays occur? Yes. Does that mean the company is "no longer providing test results..."? I don't think so.
As I mentioned before, a backlog is what is known as a "quality" problem to have. It is a problem, certainly. But one that could, conceivably, be resolved favorably. There are much worse problems that companies can have, than a backlog that occurs during a financing pinch.
Always assuming the worst is not a strategy I employ, because I do not find it useful, nor do I consider it to be fair or constructive. I try to take a much broader, and more realistic, view, based on all available evidence, and reasonable assessments of the company's potential future earnings, returns for shareholders, and likelihood thereof. People who invest in microcap research and development stocks, particularly ones that have known issues (like a financing pinch,) should understand the risks they are assuming, or they should not invest in such stocks.
I make my own assessments and decisions, and assume risks as I so choose. Everyone needs to make their own informed decisions. I've never asked anyone to invest in anything, or avoid investing in anything, merely because of my own opinions.
Daniel Gannon
Portland, Oregon, USA
